Skip to main content
SpringerLink
Log in

Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Non-alcoholic fatty liver disease (NAFLD) is closely associated with several metabolic syndrome (MetS) features. We assessed whether NAFLD is significantly associated with carotid artery intima-media thickness (IMT), as a marker of subclinical atherosclerosis, and whether such association is independent of classical cardiovascular risk factors and MetS features. We studied 100 diet-controlled Type 2 diabetic patients with ultrasonographically diagnosed NAFLD and 100 diabetic patients without NAFLD who were comparable for age and sex. Main outcome measures were carotid IMT (by ultrasonography), classical risk factors, insulin resistance [as estimated by homeostasis model assessment (HOMA)-IR] and MetS (as defined by the Adult Treatment Panel III criteria). NAFLD patients had a markedly greater carotid IMT (1.24±0.13 vs 0.95±0.11 mm; p<0.001) than those without the condition. The MetS and all its clinical traits were more highly prevalent in those with NAFLD (p<0.001). Adjustment for age, sex, smoking history, diabetes duration, glycosylated hemoglobin, LDL cholesterol, liver enzymes and microalbuminuria did not really affect the significant differences in carotid IMT that were observed between the groups. Further adjustment for the MetS also had little impact, but additional adjustment for HOMA-IR score consistently attenuated any statistical significance (p=0.28). In multivariate regression analysis, HO-MA-IR score along with age and MetS (principally raised blood pressure values) were independently related to carotid IMT, whereas NAFLD was not. In conclusion, these results suggest that among diet-controlled Type 2 diabetic individuals the significant increase of carotid IMT in the presence of NAFLD is largely explained by HOMA-estimated insulin resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346: 1221–31.

    Article  PubMed  CAS  Google Scholar 

  2. Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004, 27: 2057–66.

    Article  PubMed  Google Scholar 

  3. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37: 917–23.

    Article  PubMed  Google Scholar 

  4. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24: 683–9.

    Article  PubMed  CAS  Google Scholar 

  5. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110: 1245–50.

    Article  PubMed  Google Scholar 

  6. Bonora E, Targher G, Formentini G, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004, 21: 52–8.

    CAS  Google Scholar 

  7. Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in nondiabetic men. Role of visceral adipose tissue. Diabet Med 2005, 22: 1354–8.

    CAS  Google Scholar 

  8. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men. Role of visceral fat accumulation. Diabetes Care 2004, 27: 1498–500.

    Google Scholar 

  9. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis. A case-control study. Arterioscler Thromb Vasc Biol 2005, 25: 1045–50.

    Article  CAS  Google Scholar 

  10. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285: 2486–97.

    Article  Google Scholar 

  11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412–9.

    Article  PubMed  CAS  Google Scholar 

  12. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23: 57–63.

    CAS  Google Scholar 

  13. Bonora E, Tessari R, Micciolo R, et al. Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic subjects: relationship with insulin resistance. Diabetes Care 1997, 20: 627–31.

    Article  PubMed  CAS  Google Scholar 

  14. O’Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002, 90: 18–21.

    Article  Google Scholar 

  15. Volzke H, Robinson DM, Kleine V, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastronterol 2005, 11: 1848–53.

    Google Scholar 

  16. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21: 697–738.

    Article  PubMed  CAS  Google Scholar 

  17. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365: 1333–46.

    Article  PubMed  CAS  Google Scholar 

  18. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004, 99: 1497–502.

    Article  PubMed  CAS  Google Scholar 

  19. Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and post-prandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37: 909–16.

    Article  PubMed  CAS  Google Scholar 

  20. Targher G, Bertolini L, Scala L, Poli F, Zenari L, Falezza G. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol (Oxf) 2004, 61: 700–3.

    Article  CAS  Google Scholar 

  21. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004, 40: 46–54.

    Article  PubMed  CAS  Google Scholar 

  22. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991, 43: 26–31.

    Article  PubMed  CAS  Google Scholar 

  23. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123: 745–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Italy

    G. Targher MD, L. Bertolini, R. Padovani, L. Scala, L. Zenari & G. Falezza

  2. Department of Radiology, “Sacro Cuore” Hospital, Negrar (VR), Italy

    F. Poli

  3. Division of Endocrinology and Metabolic Diseases, University of Verona, Verona, Italy

    G. Zoppini

Authors
  1. G. Targher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Bertolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Padovani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Poli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Scala
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Zenari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Zoppini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Falezza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Targher MD.

Additional information

This study was awarded at the XV National Congress of the Italian Association of Clinical Diabetologists (AMD) in Genova, Italy, 18–21 May 2005.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Targher, G., Bertolini, L., Padovani, R. et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients. J Endocrinol Invest 29, 55–60 (2006). https://doi.org/10.1007/BF03349177

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349177

Key-words

Search

Navigation